What is Calibrate Health, Inc.?
Headquartered in New York City, Calibrate Health, Inc. operates as a specialized telemedicine platform dedicated to sustainable weight loss and metabolic health management. By integrating clinical expertise with data-driven digital tools, the company addresses the complex physiological and behavioral factors associated with weight management. Its market position is defined by a focus on long-term health outcomes rather than temporary interventions, positioning it as a disruptive force in the digital health sector. The company leverages a comprehensive care model that connects patients with medical professionals, effectively bridging the gap between traditional clinical care and modern consumer-facing health technology.
How much funding has Calibrate Health, Inc. raised?
Calibrate Health, Inc. has raised a total of $127.6M across 3 funding rounds:
Angel/Seed
$5.1M
Series A
$22.5M
Series B
$100M
Angel/Seed (2020): $5.1M with participation from Forerunner Ventures
Series A (2021): $22.5M led by Forerunner Ventures, Threshold Ventures, and Redesign Health
Series B (2021): $100M supported by Threshold Ventures, Optum Ventures, Tiger Global Management, and Founders Fund
Key Investors in Calibrate Health, Inc.
Forerunner Ventures
A venture capital firm that partners with founders to build category-defining companies at the intersection of technology and human behavior, focusing on consumer-centric innovation.
Threshold Ventures
An investment firm providing hands-on mentorship and strategic guidance to startups, assisting with market research, sales channel development, and business scaling.
Redesign Health
A healthcare-focused venture studio that ideates, builds, and scales innovative solutions to address the most significant challenges in the modern health landscape.
What's next for Calibrate Health, Inc.?
With the successful closure of its latest funding round, Calibrate Health, Inc. is well-positioned to accelerate its product development and market penetration. The influx of capital will likely be directed toward enhancing its proprietary digital infrastructure, expanding its clinical network, and refining its patient engagement strategies. As the company transitions into this next phase of maturity, the focus will shift toward achieving operational scale and demonstrating long-term efficacy in a crowded wellness market. Strategic priorities will likely include deepening partnerships with healthcare providers and potentially exploring new therapeutic areas that complement its existing metabolic health framework, ensuring the company remains at the forefront of the digital health revolution.
See full Calibrate Health, Inc. company page
